3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Other solid neoplasm
1
Genitourinary
1
CNS
1
Conditions
Wilms Tumor
1
Unspecified Childhood Solid Tumor, Protocol Specific
1
Unspecified Adult Solid Tumor, Protocol Specific
1
Sarcoma, Ewing
1
Rhabdomyosarcoma
1
Retinoblastoma
1
Osteosarcoma
1
Neuroectodermal Tumors, Primitive
1
Medulloblastoma
1
Glioma
1
Interventions
Granulocyte Colony-Stimulating Factor
2
Cyclophosphamide
2
racotumomab
1
pembrolizumab
1
pegylated granulocyte colony-stimulating factor
1
omburtamab I-131
1
cixutumumab
1
Topotecan
1
Thiotepa
1
Thalidomide
1
Sirolimus
1
Simvastatin
1
Peripheral Blood Stem Cell Transplantation
1
Melphalan
1
Imatinib Mesylate
1
Filgrastim
1
Busulfan
1
Bone Marrow Transplantation
1
Biological Factors
1
Amifostine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Sarcoma, Ewing
×
Thalidomide
×
Other solid neoplasm
×
Clear all
NCT01661400
2024-01-31
ASCR
Washington University School of Medicine
Phase 1
Completed
14 enrolled